InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Wednesday, 01/17/2018 5:56:34 AM

Wednesday, January 17, 2018 5:56:34 AM

Post# of 807
New Deals
In -house drugs progressing
DLBCL approval
DLBCL, ALL profits
2nd and further CAR Ts
Orchard approval for ADA-SCID
New In-house programs including Green Cross
TRiP sales
Possible USA listing
Possible buy out, etc.

Even a few of those may have a dramatic affect on the share price.
The next 1-2 yrs should be interesting.